HOME >> BIOLOGY >> NEWS
Molecular therapeutics advance fight against brain cancer

(Philadelphia, PA) -- An estimated 41,000 new cases of primary brain tumors are expected to be diagnosed in 2004, according to the American Brain Tumor Association. To further narrow the gap between diagnosis and effective therapy, physicians at the University of Pennsylvania Health System now offer several promising approaches to brain tumor treatment, including novel imaging for oncologic neurosurgery and refined genetic testing for tumors to better target treatment.

Through enhanced magnetic resonance imaging (MRI), newer and broader information is helping to better guide tumor removal. MRI is used to measure the anatomy and metabolism of tumors. This informs surgeons pre- and post-operatively with a three-dimensional map of tumor-associated blood flow to more precisely assess the full extent of tumor growth versus conventional imaging methods. "This novel approach helps guide surgery and assessment of treatment response," says Donald M. O'Rourke, M.D., Associate Professor of Neurosurgery. These novel imaging methods are leading to increased patient survival by allowing for greater tumor removal in a safe manner.

Neuroscientists are also ushering in a new era in which genetics will dictate treatment. In the 1990s researchers noted that a more favorable prognosis in patients with certain brain tumors, primarily oligodendrogliomas, was associated with a deletion of genes on chromosomes 1 and 19. This genetic loss translates into a significant life-expectancy gain for some patients and is therefore a robust predictor that post-surgery chemotherapy should be given to such patients.

Patients with the genetic deletion on chromosome 1 have a median survival in certain cases of about 10 years and respond particularly well to chemotherapy given immediately after surgery. Patients with the deletion have slower-growing tumors and show a better response to chemotherapy; whereas, those without the deletion have relatively faster-growing tumors and are
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
4-Aug-2004


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular motor shuttles key protein in response to light
7. Molecular traffic cop directs cellular signals
8. Molecular marker predicts success of breast cancer treatment
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Kenall has enhanced the popular MedMaster MAEC Series ... redesigned linear overbed luminaires are equipped with symmetric ambient and asymmetric exam modes, and ... , Intended to be specified in pairs, the MAEC is 8” x 48” and ...
(Date:11/7/2018)... ... November 07, 2018 , ... Features such ... adjust to last-minute changes all contribute to client retention and referral business in ... travel and expense services provider says 80 percent of its new business is ...
(Date:11/6/2018)... (PRWEB) , ... November 06, 2018 , ... uBiome, the ... Biochemistry and Biophysics at the University of California, San Francisco (UCSF) and Co-President of ... a scientific adviser to uBiome since 2013, and we are honored that he is ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research ... the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based ...
(Date:10/31/2018)... ... 2018 , ... Myoscience, Inc. announced today that it has ... Tennessee. This study enrolled 125 patients and compares the effect of cryoanalgesia ... total knee replacement surgery (TKA). , The Myoscience iovera° system is currently being ...
(Date:10/29/2018)... (PRWEB) , ... October 29, 2018 , ... PracticeMatch ... employers nationwide, released its schedule of physician career fairs planned for 2019. The company ... will focus hosting live events in the areas of the country which have the ...
(Date:10/24/2018)... , ... October 22, 2018 , ... ... research scientists, clinicians, and medical experts from around the world, will host its ... will focus on best practices in testing, chromatography, centrifugation, as well as developments ...
Breaking Biology Technology:
Cached News: